Tectonic Therapeutic (TECX) Enterprise Value (2018 - 2026)

Tectonic Therapeutic (TECX) has reported Enterprise Value for 10 consecutive years, with -$236.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value rose 22.64% year-over-year to -$236.9 million; the TTM figure through Mar 2026 stood at -$236.9 million (up 22.64% YoY), while the FY2025 annual figure was -$254.4 million, down 80.11% from the prior year.
• Enterprise Value rose to -$236.9 million in Q1 2026 per TECX's latest filing, from -$254.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$6.6 million in Q3 2023 and bottomed at -$306.2 million in Q1 2025.
• Historically, Enterprise Value has averaged -$146.2 million across 5 years, with a median of -$141.2 million in 2024.
• Annual changes were most pronounced in 2023 — Enterprise Value surged 94.32% — and 2024, when it plunged 2305.79%.
• Tectonic Therapeutic's Enterprise Value stood at -$92.8 million in 2022, then soared by 68.71% to -$29.1 million in 2023, then sank by 386.16% to -$141.2 million in 2024, then plunged by 80.11% to -$254.4 million in 2025, then climbed by 6.87% to -$236.9 million in 2026.
• Business Quant data shows TECX's Enterprise Value at -$236.9 million in Q1 2026, -$254.4 million in Q4 2025, and -$269.0 million in Q3 2025.